US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Neurosense Therapeutics Ltd

0.4267

+0.00631.50%

Post-market: 0.4260-0.0007-0.16%19:53 EDT

Volume:167.90K

Turnover:72.21K

Market Cap:16.11M

PE:-0.98

High:0.4500

Open:0.4500

Low:0.4052

Close:0.4204

52wk High:1.98

52wk Low:0.2500

Shares:37.77M

Float Shares:25.85M

Volume Ratio:1.18

T/O Rate:0.65%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4366

EPS(LYR):-0.4366

ROE:-2174.98%

ROA:-247.30%

PB:-10.33

PE(LYR):-0.98

Loading ...

Overview Company News Filings

Israel's NeuroSense Therapeutics 2025 net loss widens as expenses rise

BRIEF-NeuroSense Therapeutics FY EPS USD -0.44

Neurosense Therapeutics FY Operating Income USD -11.085 Million

THOMSON REUTERS

Neurosense Therapeutics FY EPS USD -0.44

THOMSON REUTERS

Press Release: NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update

NeuroSense files Form 3 for CTO Niva Russek-Blum initial beneficial ownership

NeuroSense CEO Alon Ben-Noon files initial beneficial ownership statement

NeuroSense to report clinical and biomarker results from Alzheimer’s study in coming weeks

NeuroSense Therapeutics Director Cary J. Claiborne Files Initial Beneficial Ownership Statement

NeuroSense Therapeutics Ltd. Director Roy Golan Files Initial Beneficial Ownership Statement

NeuroSense Therapeutics Ltd. Director Mark Leuchtenberger Files Initial Beneficial Ownership Statement

NeuroSense Therapeutics Ltd. files Form 3 initial beneficial ownership statement for General Manager Hagit Binder

NeuroSense to Present PrimeC Phase 2b PARADIGM Data at AD/PD 2026 Conference

Health Rounds: Blood test improves detection of endometriosis

Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN), Assertio Therapeutics (ASRT) and LENSAR (LNSR)

NeuroSense Phase 2b PARADIGM trial links PrimeC to 36% slower ALS progression and 64% lower complication risk

Jama Neurology Publishes Results From Paradigm Phase 2B Trial of Primec in ALS Demonstrating Meaningful Clinical Outcomes and Biological Activity

THOMSON REUTERS

NeuroSense Therapeutics shareholders approve articles amendment to increase registered share capital

Roth Capital Partners Initiates Neurosense Therapeutics at Buy

MT Newswires Live

NeuroSense initiated with a Buy at Roth Capital

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/NRSN/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NRSN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRSN\",,,,,undefined,":{"symbol":"NRSN","market":"US","secType":"STK","nameCN":"Neurosense Therapeutics Ltd","latestPrice":0.4267,"timestamp":1788206400000,"preClose":0.4204,"halted":0,"volume":167900,"hourTrading":{"tag":"盘后","latestPrice":0.426,"preClose":0.4267,"latestTime":"19:53 EDT","volume":649,"amount":274.2431,"timestamp":1788220393467,"change":-0.0007,"changeRate":-0.00164,"amplitude":0.01992},"delay":0,"changeRate":0.014985727878211294,"floatShares":25846403,"shares":37766100,"eps":-0.436593,"marketStatus":"Closed","change":0.0063,"latestTime":"08-31 16:00:00 EDT","open":0.45,"high":0.45,"low":0.4052,"amount":72208.38362,"amplitude":0.106565,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.436593,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788249600000},"marketStatusCode":5,"adr":0,"listingDate":1639026000000,"exchange":"NASDAQ","adjPreClose":0.4204,"preHourTrading":{"tag":"盘前","latestPrice":0.4565,"preClose":0.4204,"latestTime":"09:27 EDT","volume":4588,"amount":2044.752312,"timestamp":1788182865947,"change":0.0361,"changeRate":0.085871,"amplitude":0.18078},"postHourTrading":{"tag":"盘后","latestPrice":0.426,"preClose":0.4267,"latestTime":"19:53 EDT","volume":649,"amount":274.2431,"timestamp":1788220393467,"change":-0.0007,"changeRate":-0.00164,"amplitude":0.01992},"volumeRatio":1.177808},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NRSN\",,,,,undefined,":{"symbol":"NRSN","floatShares":25846403,"roa":"-247.30%","roe":"-2174.98%","lyrEps":-0.436593,"volumeRatio":1.177808,"shares":37766100,"dividePrice":0,"high":0.45,"amplitude":0.106565,"preClose":0.4204,"low":0.4052,"week52Low":0.25,"pbRate":"-10.33","week52High":1.98,"institutionHeld":0,"latestPrice":0.4267,"eps":-0.436593,"divideRate":0,"volume":167900,"delay":0,"ttmEps":-0.436593,"open":0.45,"prevYearClose":0.769,"prevWeekClose":0.4204,"prevMonthClose":0.4652,"prevQuarterClose":0.72,"fiveDayClose":0.375,"twentyDayClose":0.467,"sixtyDayClose":0.7801},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NRSN\",params:#limit:5,,,undefined,":[{"date":"2026-03-31","symbol":"NRSN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774944000000,"name":null,"time":"Pre-MKt","dateTimestamp":1774929600000,"actualEps":null},{"market":"US","date":"2025-08-01","symbol":"NRSN","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754020800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-04-07","symbol":"NRSN","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1743998400000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2024-12-18","symbol":"NRSN","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1734498000000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2024-06-24","symbol":"NRSN","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1719201600000,"reportTimeType":"pre","actualEps":-0.35}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NRSN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NRSN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1773374400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NRSN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NRSN","date":"2026-08-28","current":-0.97734,"percent":0.833191,"low":-12.966568,"twenty":-3.571281,"median":-2.343329,"eighty":-1.558666,"high":-0.395084,"avg":-2.691772,"sd":1.550416,"marketCap":16227478},"quantilePoints":[{"date":"2021-12-10","current":-6.574093,"twenty":-10.190888,"median":-8.533367,"eighty":-7.593999,"marketCap":34566580},{"date":"2021-12-17","current":-6.369292,"twenty":-8.481481,"median":-7.033255,"eighty":-6.696973,"marketCap":33489739},{"date":"2021-12-23","current":-6.010892,"twenty":-7.839759,"median":-6.778893,"eighty":-6.385676,"marketCap":31605268},{"date":"2021-12-31","current":-5.03809,"twenty":-7.126398,"median":-6.420492,"eighty":-5.387602,"marketCap":26490276},{"date":"2022-01-07","current":-5.24289,"twenty":-6.939702,"median":-6.041612,"eighty":-5.268367,"marketCap":27567116},{"date":"2022-01-14","current":-5.632011,"twenty":-6.791181,"median":-5.652491,"eighty":-5.268367,"marketCap":29613113},{"date":"2022-01-21","current":-4.812809,"twenty":-6.737933,"median":-5.611531,"eighty":-5.166254,"marketCap":25305751},{"date":"2022-01-28","current":-3.829767,"twenty":-6.545421,"median":-5.509131,"eighty":-4.931594,"marketCap":20136917},{"date":"2022-02-04","current":-3.725547,"twenty":-6.426636,"median":-5.37601,"eighty":-4.251656,"marketCap":19588925},{"date":"2022-02-11","current":-3.663107,"twenty":-6.40206,"median":-5.24289,"eighty":-3.929516,"marketCap":19260619},{"date":"2022-02-18","current":-3.267658,"twenty":-6.303756,"median":-5.10977,"eighty":-3.725547,"marketCap":17181348},{"date":"2022-02-25","current":-3.14278,"twenty":-6.041612,"median":-5.01761,"eighty":-3.663107,"marketCap":16524736},{"date":"2022-03-04","current":-3.954491,"twenty":-6.010892,"median":-4.91521,"eighty":-3.683921,"marketCap":20792714},{"date":"2022-03-11","current":-2.934649,"twenty":-5.672971,"median":-4.706253,"eighty":-3.645447,"marketCap":15430382},{"date":"2022-03-18","current":-3.246845,"twenty":-5.652491,"median":-4.464649,"eighty":-3.267658,"marketCap":17071913},{"date":"2022-03-25","current":-8.783133,"twenty":-6.369292,"median":-4.706253,"eighty":-3.352784,"marketCap":46181713},{"date":"2022-04-01","current":-7.804917,"twenty":-6.778893,"median":-4.91521,"eighty":-3.579855,"marketCap":41038252},{"date":"2022-04-08","current":-5.89011,"twenty":-7.033255,"median":-5.04833,"eighty":-3.621481,"marketCap":30970201},{"date":"2022-04-14","current":-5.470413,"twenty":-6.846149,"median":-5.01761,"eighty":-3.640654,"marketCap":22105938},{"date":"2022-04-22","current":-6.4995,"twenty":-6.782989,"median":-5.16097,"eighty":-3.659575,"marketCap":26264481},{"date":"2022-04-29","current":-4.54965,"twenty":-6.615053,"median":-5.207035,"eighty":-3.663107,"marketCap":18385137},{"date":"2022-05-06","current":-4.197594,"twenty":-6.514419,"median":-5.05857,"eighty":-3.663107,"marketCap":16962477},{"date":"2022-05-13","current":-3.439319,"twenty":-6.444486,"median":-4.985732,"eighty":-3.653865,"marketCap":13898288},{"date":"2022-05-20","current":-4.073327,"twenty":-6.414348,"median":-4.894729,"eighty":-3.613156,"marketCap":16460316},{"date":"2022-05-27","current":-4.304438,"twenty":-6.377484,"median":-4.641324,"eighty":-3.640654,"marketCap":17394234},{"date":"2022-06-03","current":-3.629217,"twenty":-6.349925,"median":-4.548658,"eighty":-3.579438,"marketCap":16810535},{"date":"2022-06-10","current":-3.679623,"twenty":-6.207023,"median":-4.495488,"eighty":-3.604831,"marketCap":17044015},{"date":"2022-06-17","current":-4.183681,"twenty":-6.073112,"median":-4.437259,"eighty":-3.626123,"marketCap":19378811},{"date":"2022-06-24","current":-4.284493,"twenty":-6.029324,"median":-4.307067,"eighty":-3.635709,"marketCap":19845771},{"date":"2022-07-01","current":-8.316957,"twenty":-6.35638,"median":-4.441325,"eighty":-3.649036,"marketCap":38524143},{"date":"2022-07-08","current":-6.754377,"twenty":-6.429933,"median":-4.495488,"eighty":-3.65473,"marketCap":31286274},{"date":"2022-07-15","current":-5.191797,"twenty":-6.429933,"median":-4.548658,"eighty":-3.657397,"marketCap":24048404},{"date":"2022-07-22","current":-4.61213,"twenty":-6.423442,"median":-4.61213,"eighty":-3.663107,"marketCap":21363388},{"date":"2022-07-29","current":-4.712942,"twenty":-6.40206,"median":-4.762875,"eighty":-3.663107,"marketCap":21830348},{"date":"2022-08-05","current":-4.788551,"twenty":-6.362836,"median":-4.788551,"eighty":-3.66641,"marketCap":22180567},{"date":"2022-08-12","current":-5.368217,"twenty":-6.329755,"median":-4.80068,"eighty":-3.680483,"marketCap":24865583},{"date":"2022-08-19","current":-4.939768,"twenty":-6.265441,"median":-4.838957,"eighty":-3.683921,"marketCap":22881006},{"date":"2022-08-26","current":-5.04058,"twenty":-6.123516,"median":-4.892046,"eighty":-3.688102,"marketCap":23347966},{"date":"2022-09-02","current":-3.184552,"twenty":-6.104613,"median":-4.889362,"eighty":-3.680483,"marketCap":22881006},{"date":"2022-09-09","current":-3.265791,"twenty":-6.041612,"median":-4.838957,"eighty":-3.663107,"marketCap":23464705},{"date":"2022-09-16","current":-3.2008,"twenty":-6.023493,"median":-4.80068,"eighty":-3.629217,"marketCap":22997746},{"date":"2022-09-23","current":-2.599634,"twenty":-6.010892,"median":-4.738145,"eighty":-3.553609,"marketCap":18678372},{"date":"2022-09-30","current":-2.908341,"twenty":-5.930794,"median":-4.697946,"eighty":-3.4664,"marketCap":20896429},{"date":"2022-10-07","current":-2.745864,"twenty":-5.89011,"median":-4.61213,"eighty":-3.363277,"marketCap":19729031},{"date":"2022-10-14","current":-2.778359,"twenty":-5.822469,"median":-4.548658,"eighty":-3.298286,"marketCap":19962510},{"date":"2022-10-21","current":-2.518396,"twenty":-5.795388,"median":-4.495488,"eighty":-3.249543,"marketCap":18094673},{"date":"2022-10-28","current":-2.469653,"twenty":-5.741225,"median":-4.437259,"eighty":-3.184552,"marketCap":17744454},{"date":"2022-11-04","current":-2.420909,"twenty":-5.723606,"median":-4.304438,"eighty":-3.168304,"marketCap":17394234},{"date":"2022-11-11","current":-2.453405,"twenty":-5.672971,"median":-4.278838,"eighty":-3.11156,"marketCap":17627714},{"date":"2022-11-18","current":-3.005177,"twenty":-5.670652,"median":-4.198408,"eighty":-3.038323,"marketCap":21592198},{"date":"2022-11-25","current":-2.84335,"twenty":-5.656123,"median":-4.197594,"eighty":-2.986918,"marketCap":20429470},{"date":"2022-12-02","current":-2.117174,"twenty":-5.636107,"median":-4.157963,"eighty":-2.932864,"marketCap":19670661},{"date":"2022-12-09","current":-1.985243,"twenty":-5.599243,"median":-4.108073,"eighty":-2.912736,"marketCap":18444893},{"date":"2022-12-16","current":-1.758322,"twenty":-5.574667,"median":-4.076348,"eighty":-2.875845,"marketCap":16336571},{"date":"2022-12-23","current":-1.633428,"twenty":-5.521419,"median":-3.954491,"eighty":-2.820603,"marketCap":15176177},{"date":"2022-12-30","current":-1.532909,"twenty":-5.4859,"median":-3.928883,"eighty":-2.778359,"marketCap":14242259},{"date":"2023-01-06","current":-1.584048,"twenty":-5.469859,"median":-3.892052,"eighty":-2.752363,"marketCap":14717390},{"date":"2023-01-13","current":-1.696252,"twenty":-5.468686,"median":-3.836529,"eighty":-2.70362,"marketCap":15759877},{"date":"2023-01-20","current":-2.257227,"twenty":-5.456819,"median":-3.807103,"eighty":-2.664625,"marketCap":20971894},{"date":"2023-01-27","current":-2.143097,"twenty":-5.410473,"median":-3.730029,"eighty":-2.632,"marketCap":19911517},{"date":"2023-02-03","current":-2.067011,"twenty":-5.399028,"median":-3.715187,"eighty":-2.586636,"marketCap":19204599},{"date":"2023-02-10","current":-2.117735,"twenty":-5.363632,"median":-3.683921,"eighty":-2.56064,"marketCap":19675878},{"date":"2023-02-17","current":-2.472805,"twenty":-5.337817,"median":-3.663107,"eighty":-2.498898,"marketCap":22974827},{"date":"2023-02-24","current":-2.586934,"twenty":-5.307925,"median":-3.659538,"eighty":-2.469653,"marketCap":24035204},{"date":"2023-03-03","current":-2.181267,"twenty":-5.306583,"median":-3.645447,"eighty":-2.421072,"marketCap":20266154},{"date":"2023-03-10","current":-2.168459,"twenty":-5.292609,"median":-3.600668,"eighty":-2.384037,"marketCap":20147156},{"date":"2023-03-17","current":-2.29527,"twenty":-5.24289,"median":-3.553609,"eighty":-2.307663,"marketCap":21325353},{"date":"2023-03-24","current":-1.662583,"twenty":-5.226682,"median":-3.507022,"eighty":-2.269908,"marketCap":20516275},{"date":"2023-03-31","current":-1.643473,"twenty":-5.217,"median":-3.439319,"eighty":-2.231865,"marketCap":20280456},{"date":"2023-04-06","current":-1.624363,"twenty":-5.196838,"median":-3.395772,"eighty":-2.206503,"marketCap":20044637},{"date":"2023-04-14","current":-1.595698,"twenty":-5.188271,"median":-3.35543,"eighty":-2.181242,"marketCap":19690908},{"date":"2023-04-21","current":-1.834574,"twenty":-5.170753,"median":-3.298286,"eighty":-2.165923,"marketCap":22638648},{"date":"2023-04-28","current":-1.815464,"twenty":-5.162095,"median":-3.266725,"eighty":-2.132364,"marketCap":22402829},{"date":"2023-05-05","current":-1.663852,"twenty":-5.104983,"median":-3.246845,"eighty":-2.105764,"marketCap":20531935},{"date":"2023-05-12","current":-1.663852,"twenty":-5.090986,"median":-3.192676,"eighty":-2.067939,"marketCap":20531935},{"date":"2023-05-19","current":-1.635165,"twenty":-5.090986,"median":-3.184406,"eighty":-2.021262,"marketCap":20177936},{"date":"2023-05-26","current":-1.577791,"twenty":-5.070824,"median":-3.160181,"eighty":-1.98273,"marketCap":19469938},{"date":"2023-05-30","current":-1.529979,"twenty":-5.065783,"median":-3.152057,"eighty":-1.972678,"marketCap":18879940},{"date":"2023-06-09","current":-1.667747,"twenty":-5.05857,"median":-3.123684,"eighty":-1.940201,"marketCap":22537929},{"date":"2023-06-16","current":-1.606625,"twenty":-5.04058,"median":-3.08034,"eighty":-1.922419,"marketCap":21711931},{"date":"2023-06-23","current":-1.397065,"twenty":-5.04058,"median":-3.038323,"eighty":-1.882,"marketCap":18879940},{"date":"2023-06-30","current":-1.257359,"twenty":-5.04058,"median":-2.989579,"eighty":-1.815464,"marketCap":16991946},{"date":"2023-07-07","current":-1.340783,"twenty":-5.039584,"median":-2.976275,"eighty":-1.751128,"marketCap":18119348},{"date":"2023-07-14","current":-1.331068,"twenty":-5.029005,"median":-2.934649,"eighty":-1.709433,"marketCap":17988049},{"date":"2023-07-21","current":-1.388002,"twenty":-5.015377,"median":-2.924589,"eighty":-1.68025,"marketCap":18757465},{"date":"2023-07-28","current":-1.32057,"twenty":-5.008078,"median":-2.911088,"eighty":-1.663852,"marketCap":17846185},{"date":"2023-08-04","current":-1.02823,"twenty":-4.994348,"median":-2.893022,"eighty":-1.662583,"marketCap":13895502},{"date":"2023-08-11","current":-1.018149,"twenty":-4.983838,"median":-2.859598,"eighty":-1.65429,"marketCap":13759272},{"date":"2023-08-18","current":-0.785704,"twenty":-4.970589,"median":-2.827102,"eighty":-1.643975,"marketCap":11988276},{"date":"2023-08-25","current":-0.803651,"twenty":-4.964971,"median":-2.794607,"eighty":-1.64232,"marketCap":12262100},{"date":"2023-09-01","current":-0.839275,"twenty":-4.95489,"median":-2.778359,"eighty":-1.635165,"marketCap":12805659},{"date":"2023-09-08","current":-0.832936,"twenty":-4.939768,"median":-2.762111,"eighty":-1.633428,"marketCap":12708935},{"date":"2023-09-15","current":-0.76508,"twenty":-4.939768,"median":-2.737821,"eighty":-1.624363,"marketCap":11673584},{"date":"2023-09-22","current":-0.785526,"twenty":-4.939768,"median":-2.697121,"eighty":-1.608262,"marketCap":11985552},{"date":"2023-09-29","current":-0.669634,"twenty":-4.934856,"median":-2.664625,"eighty":-1.59597,"marketCap":10217281},{"date":"2023-10-06","current":-0.521511,"twenty":-4.911114,"median":-2.63213,"eighty":-1.584467,"marketCap":7957218},{"date":"2023-10-13","current":-0.508922,"twenty":-4.893656,"median":-2.599634,"eighty":-1.571801,"marketCap":7765133},{"date":"2023-10-20","current":-0.482315,"twenty":-4.889362,"median":-2.586934,"eighty":-1.557715,"marketCap":7359167},{"date":"2023-10-27","current":-0.420977,"twenty":-4.889362,"median":-2.583386,"eighty":-1.550731,"marketCap":6423264},{"date":"2023-11-03","current":-0.427673,"twenty":-4.859119,"median":-2.575182,"eighty":-1.529941,"marketCap":6525437},{"date":"2023-11-10","current":-0.473207,"twenty":-4.838957,"median":-2.534643,"eighty":-1.428226,"marketCap":7220198},{"date":"2023-11-17","current":-0.458923,"twenty":-4.823268,"median":-2.50621,"eighty":-1.39344,"marketCap":7002243},{"date":"2023-11-24","current":-0.573296,"twenty":-4.803106,"median":-2.471229,"eighty":-1.365256,"marketCap":8747355},{"date":"2023-12-01","current":-1.530812,"twenty":-4.788551,"median":-2.434888,"eighty":-1.354573,"marketCap":17573724},{"date":"2023-12-08","current":-0.947576,"twenty":-4.768389,"median":-2.421072,"eighty":-1.344766,"marketCap":10878169},{"date":"2023-12-15","current":-1.035548,"twenty":-4.728064,"median":-2.409536,"eighty":-1.33788,"marketCap":11888089},{"date":"2023-12-22","current":-0.924958,"twenty":-4.712942,"median":-2.352334,"eighty":-1.320883,"marketCap":10618514},{"date":"2023-12-29","current":-0.928529,"twenty":-4.712942,"median":-2.34536,"eighty":-1.310489,"marketCap":10659512},{"date":"2024-01-05","current":-0.929719,"twenty":-4.694947,"median":-2.307807,"eighty":-1.276215,"marketCap":10673178},{"date":"2024-01-12","current":-1.105068,"twenty":-4.65558,"median":-2.29527,"eighty":-1.218395,"marketCap":12686186},{"date":"2024-01-19","current":-1.130782,"twenty":-4.627252,"median":-2.269908,"eighty":-1.115354,"marketCap":12981373},{"date":"2024-01-26","current":-1.226134,"twenty":-4.607157,"median":-2.231865,"eighty":-1.134639,"marketCap":14076023},{"date":"2024-02-02","current":-1.541596,"twenty":-4.579679,"median":-2.219184,"eighty":-1.141376,"marketCap":17697524},{"date":"2024-02-09","current":-1.571357,"twenty":-4.548856,"median":-2.206503,"eighty":-1.166661,"marketCap":18039175},{"date":"2024-02-16","current":-1.583261,"twenty":-4.543502,"median":-2.181267,"eighty":-1.20534,"marketCap":18175835},{"date":"2024-02-23","current":-1.499931,"twenty":-4.528904,"median":-2.18114,"eighty":-1.210592,"marketCap":17219212},{"date":"2024-03-01","current":-2.107047,"twenty":-4.48932,"median":-2.162119,"eighty":-1.21423,"marketCap":24188894},{"date":"2024-03-08","current":-2.392748,"twenty":-4.459984,"median":-2.18114,"eighty":-1.214653,"marketCap":27468744},{"date":"2024-03-15","current":-1.654686,"twenty":-4.439699,"median":-2.162119,"eighty":-1.217027,"marketCap":18995798},{"date":"2024-03-22","current":-2.154663,"twenty":-4.408494,"median":-2.143097,"eighty":-1.221037,"marketCap":24735536},{"date":"2024-03-28","current":-2.05943,"twenty":-4.309696,"median":-2.142759,"eighty":-1.226134,"marketCap":23642252},{"date":"2024-04-05","current":-2.452269,"twenty":-4.304438,"median":-2.155221,"eighty":-1.239925,"marketCap":28152046},{"date":"2024-04-12","current":-2.323708,"twenty":-4.284493,"median":-2.154663,"eighty":-1.257359,"marketCap":26211430},{"date":"2024-04-19","current":-2.102403,"twenty":-4.278838,"median":-2.155221,"eighty":-1.270167,"marketCap":23715103},{"date":"2024-04-26","current":-1.936249,"twenty":-4.278838,"median":-2.143097,"eighty":-1.279703,"marketCap":21840892},{"date":"2024-05-03","current":-1.951616,"twenty":-4.234087,"median":-2.139758,"eighty":-1.280247,"marketCap":22014233},{"date":"2024-05-10","current":-1.803785,"twenty":-4.198408,"median":-2.130855,"eighty":-1.285655,"marketCap":20346698},{"date":"2024-05-17","current":-1.874781,"twenty":-4.197795,"median":-2.117455,"eighty":-1.309749,"marketCap":21147531},{"date":"2024-05-24","current":-1.789876,"twenty":-4.197594,"median":-2.10806,"eighty":-1.310489,"marketCap":20189806},{"date":"2024-05-31","current":-1.927374,"twenty":-4.186464,"median":-2.105942,"eighty":-1.311407,"marketCap":19479966},{"date":"2024-06-07","current":-1.963066,"twenty":-4.163519,"median":-2.103728,"eighty":-1.318783,"marketCap":19840706},{"date":"2024-06-14","current":-1.731067,"twenty":-4.157654,"median":-2.092373,"eighty":-1.321196,"marketCap":17495895},{"date":"2024-06-21","current":-1.602576,"twenty":-4.142944,"median":-2.087988,"eighty":-1.321352,"marketCap":16197231},{"date":"2024-06-28","current":-1.604945,"twenty":-4.118154,"median":-2.074553,"eighty":-1.316996,"marketCap":20201446},{"date":"2024-07-05","current":-1.762574,"twenty":-4.104917,"median":-2.071187,"eighty":-1.320883,"marketCap":22185517},{"date":"2024-07-12","current":-1.447317,"twenty":-4.091858,"median":-2.059598,"eighty":-1.321352,"marketCap":18217376},{"date":"2024-07-19","current":-1.048373,"twenty":-4.076953,"median":-2.053627,"eighty":-1.310948,"marketCap":13195873},{"date":"2024-07-26","current":-1.159807,"twenty":-4.038661,"median":-2.035308,"eighty":-1.279921,"marketCap":14598485},{"date":"2024-08-02","current":-1.057831,"twenty":-3.973793,"median":-2.024697,"eighty":-1.246899,"marketCap":13314917},{"date":"2024-08-09","current":-0.944338,"twenty":-3.945355,"median":-2.003606,"eighty":-1.217711,"marketCap":11886386},{"date":"2024-08-16","current":-1.191124,"twenty":-3.930544,"median":-1.990733,"eighty":-1.211681,"marketCap":14992674},{"date":"2024-08-23","current":-1.283939,"twenty":-3.928042,"median":-1.985243,"eighty":-1.211681,"marketCap":16160934},{"date":"2024-08-30","current":-1.376753,"twenty":-3.912889,"median":-1.981631,"eighty":-1.20534,"marketCap":17329195},{"date":"2024-09-06","current":-1.45611,"twenty":-3.887863,"median":-1.96912,"eighty":-1.209999,"marketCap":18328057},{"date":"2024-09-13","current":-2.088334,"twenty":-3.865327,"median":-1.965563,"eighty":-1.211473,"marketCap":26285858},{"date":"2024-09-20","current":-2.010988,"twenty":-3.839942,"median":-1.981631,"eighty":-1.212692,"marketCap":25312307},{"date":"2024-09-27","current":-1.98005,"twenty":-3.830626,"median":-1.98005,"eighty":-1.21423,"marketCap":24922887},{"date":"2024-10-04","current":-2.503926,"twenty":-3.820701,"median":-1.982351,"eighty":-1.214653,"marketCap":24533467},{"date":"2024-10-11","current":-2.245584,"twenty":-3.776823,"median":-1.988004,"eighty":-1.217027,"marketCap":22002236},{"date":"2024-10-18","current":-2.12635,"twenty":-3.743094,"median":-1.988004,"eighty":-1.219877,"marketCap":20833976},{"date":"2024-10-25","current":-2.523798,"twenty":-3.729133,"median":-1.995519,"eighty":-1.221492,"marketCap":24728177},{"date":"2024-11-01","current":-2.648772,"twenty":-3.725547,"median":-2.003739,"eighty":-1.228892,"marketCap":25952672},{"date":"2024-11-08","current":-2.690697,"twenty":-3.721403,"median":-2.016604,"eighty":-1.242231,"marketCap":26363451},{"date":"2024-11-15","current":-2.565548,"twenty":-3.700645,"median":-2.030063,"eighty":-1.251762,"marketCap":25137244},{"date":"2024-11-22","current":-1.902279,"twenty":-3.683921,"median":-2.03445,"eighty":-1.253603,"marketCap":18638532},{"date":"2024-11-29","current":-2.071582,"twenty":-3.683921,"median":-2.025676,"eighty":-1.256014,"marketCap":20297362},{"date":"2024-12-06","current":-2.198189,"twenty":-3.679623,"median":-2.039563,"eighty":-1.257359,"marketCap":21537860},{"date":"2024-12-13","current":-2.029841,"twenty":-3.663107,"median":-2.043819,"eighty":-1.258879,"marketCap":19888385},{"date":"2024-12-20","current":-2.712263,"twenty":-3.663107,"median":-2.059308,"eighty":-1.270167,"marketCap":31451400},{"date":"2024-12-27","current":-2.552718,"twenty":-3.663107,"median":-2.06238,"eighty":-1.277472,"marketCap":29601318},{"date":"2025-01-03","current":-2.37323,"twenty":-3.658824,"median":-2.067591,"eighty":-1.279541,"marketCap":27519975},{"date":"2025-01-10","current":-2.074083,"twenty":-3.655349,"median":-2.072223,"eighty":-1.279921,"marketCap":24051071},{"date":"2025-01-17","current":-2.183472,"twenty":-3.650831,"median":-2.071582,"eighty":-1.281724,"marketCap":25319545},{"date":"2025-01-24","current":-2.203504,"twenty":-3.642201,"median":-2.072865,"eighty":-1.284282,"marketCap":25551835},{"date":"2025-01-31","current":-2.223536,"twenty":-3.62767,"median":-2.074377,"eighty":-1.290474,"marketCap":25784124},{"date":"2025-02-07","current":-2.323695,"twenty":-3.613156,"median":-2.083313,"eighty":-1.309897,"marketCap":26945571},{"date":"2025-02-14","current":-2.313679,"twenty":-3.579646,"median":-2.084805,"eighty":-1.310718,"marketCap":26829426},{"date":"2025-02-21","current":-2.183472,"twenty":-3.578812,"median":-2.088161,"eighty":-1.311636,"marketCap":25319545},{"date":"2025-02-28","current":-2.218528,"twenty":-3.553609,"median":-2.088334,"eighty":-1.32057,"marketCap":25726052},{"date":"2025-03-07","current":-2.2636,"twenty":-3.528406,"median":-2.093757,"eighty":-1.321352,"marketCap":26248703},{"date":"2025-03-14","current":-2.363759,"twenty":-3.520563,"median":-2.103345,"eighty":-1.321352,"marketCap":27410150},{"date":"2025-03-21","current":-2.143409,"twenty":-3.493481,"median":-2.105444,"eighty":-1.324223,"marketCap":24854966},{"date":"2025-03-28","current":-1.99317,"twenty":-3.4664,"median":-2.105834,"eighty":-1.331068,"marketCap":23112796},{"date":"2025-04-04","current":-1.983154,"twenty":-3.439319,"median":-2.103345,"eighty":-1.332821,"marketCap":22996651},{"date":"2025-04-11","current":-2.490498,"twenty":-3.439319,"median":-2.105834,"eighty":-1.335944,"marketCap":25427989},{"date":"2025-04-17","current":-2.427766,"twenty":-3.404481,"median":-2.107047,"eighty":-1.339815,"marketCap":24787491},{"date":"2025-04-25","current":-2.349292,"twenty":-3.369776,"median":-2.116704,"eighty":-1.340783,"marketCap":23986270},{"date":"2025-05-02","current":-2.420013,"twenty":-3.359115,"median":-2.117735,"eighty":-1.340783,"marketCap":24708329},{"date":"2025-05-09","current":-2.452436,"twenty":-3.353842,"median":-2.128602,"eighty":-1.340912,"marketCap":25039372},{"date":"2025-05-16","current":-3.101375,"twenty":-3.335182,"median":-2.136757,"eighty":-1.348588,"marketCap":31665043},{"date":"2025-05-23","current":-3.430309,"twenty":-3.369776,"median":-2.142759,"eighty":-1.350749,"marketCap":35023456},{"date":"2025-05-30","current":-3.52429,"twenty":-3.433913,"median":-2.143253,"eighty":-1.356454,"marketCap":35983003},{"date":"2025-06-06","current":-4.041186,"twenty":-3.504314,"median":-2.143409,"eighty":-1.360215,"marketCap":41260510},{"date":"2025-06-13","current":-5.591874,"twenty":-3.538487,"median":-2.14431,"eighty":-1.361369,"marketCap":57093032},{"date":"2025-06-20","current":-5.756341,"twenty":-3.5758,"median":-2.155221,"eighty":-1.365256,"marketCap":58772239},{"date":"2025-06-27","current":-4.652063,"twenty":-3.626123,"median":-2.155917,"eighty":-1.37266,"marketCap":47497564},{"date":"2025-07-03","current":-4.487596,"twenty":-3.655659,"median":-2.166095,"eighty":-1.377613,"marketCap":45818357},{"date":"2025-07-11","current":-4.957502,"twenty":-3.67632,"median":-2.167308,"eighty":-1.382444,"marketCap":50616091},{"date":"2025-07-18","current":-4.628568,"twenty":-3.710767,"median":-2.173056,"eighty":-1.388401,"marketCap":47257677},{"date":"2025-07-25","current":-4.769539,"twenty":-3.743094,"median":-2.179806,"eighty":-1.391411,"marketCap":48696998},{"date":"2025-08-01","current":-4.229148,"twenty":-3.830626,"median":-2.18114,"eighty":-1.400575,"marketCap":43179604},{"date":"2025-08-08","current":-3.601902,"twenty":-3.829759,"median":-2.182797,"eighty":-1.414616,"marketCap":31185269},{"date":"2025-08-15","current":-3.324649,"twenty":-3.828495,"median":-2.183472,"eighty":-1.417338,"marketCap":28784813},{"date":"2025-08-22","current":-3.239402,"twenty":-3.815734,"median":-2.185967,"eighty":-1.428226,"marketCap":28046741},{"date":"2025-08-29","current":-3.239402,"twenty":-3.776823,"median":-2.193821,"eighty":-1.432044,"marketCap":28046741},{"date":"2025-09-05","current":-3.125739,"twenty":-3.74636,"median":-2.198189,"eighty":-1.447317,"marketCap":27062645},{"date":"2025-09-12","current":-3.267818,"twenty":-3.74636,"median":-2.203504,"eighty":-1.45611,"marketCap":28292765},{"date":"2025-09-19","current":-3.499934,"twenty":-3.730029,"median":-2.203504,"eighty":-1.461647,"marketCap":30302429},{"date":"2025-09-26","current":-3.413159,"twenty":-3.725547,"median":-2.206503,"eighty":-1.469568,"marketCap":29551129},{"date":"2025-10-03","current":-3.557784,"twenty":-3.725547,"median":-2.213056,"eighty":-1.475976,"marketCap":30803295},{"date":"2025-10-10","current":-3.615634,"twenty":-3.71273,"median":-2.22136,"eighty":-1.488027,"marketCap":31304162},{"date":"2025-10-17","current":-3.528859,"twenty":-3.712252,"median":-2.22944,"eighty":-1.488027,"marketCap":30552862},{"date":"2025-10-24","current":-3.355309,"twenty":-3.704826,"median":-2.231865,"eighty":-1.488027,"marketCap":29050262},{"date":"2025-10-31","current":-2.993745,"twenty":-3.683921,"median":-2.233628,"eighty":-1.499931,"marketCap":25919846},{"date":"2025-11-07","current":-2.978993,"twenty":-3.683921,"median":-2.244576,"eighty":-1.499931,"marketCap":25792125},{"date":"2025-11-14","current":-2.653904,"twenty":-3.679623,"median":-2.261599,"eighty":-1.500506,"marketCap":22977505},{"date":"2025-11-21","current":-3.094983,"twenty":-3.673485,"median":-2.2636,"eighty":-1.507779,"marketCap":26796363},{"date":"2025-11-28","current":-3.442084,"twenty":-3.665183,"median":-2.2636,"eighty":-1.511025,"marketCap":29801562},{"date":"2025-12-05","current":-3.471009,"twenty":-3.663107,"median":-2.269908,"eighty":-1.5149,"marketCap":30051996},{"date":"2025-12-12","current":-2.574332,"twenty":-3.663107,"median":-2.279041,"eighty":-1.517364,"marketCap":22288563},{"date":"2025-12-19","current":-2.36665,"twenty":-3.657397,"median":-2.285329,"eighty":-1.52255,"marketCap":20490452},{"date":"2025-12-26","current":-2.364625,"twenty":-3.65504,"median":-2.293458,"eighty":-1.52374,"marketCap":20472922},{"date":"2026-01-02","current":-2.224338,"twenty":-3.650831,"median":-2.285329,"eighty":-1.52374,"marketCap":19258320},{"date":"2026-01-09","current":-3.217598,"twenty":-3.645092,"median":-2.29527,"eighty":-1.525769,"marketCap":27857961},{"date":"2026-01-16","current":-3.397687,"twenty":-3.655349,"median":-2.299508,"eighty":-1.52924,"marketCap":29417175},{"date":"2026-01-23","current":-3.224801,"twenty":-3.652625,"median":-2.303063,"eighty":-1.529902,"marketCap":27920329},{"date":"2026-01-30","current":-3.632927,"twenty":-3.645269,"median":-2.305663,"eighty":-1.530146,"marketCap":31453885},{"date":"2026-02-06","current":-3.327347,"twenty":-3.642233,"median":-2.313679,"eighty":-1.530812,"marketCap":28808169},{"date":"2026-02-13","current":-3.824537,"twenty":-3.655659,"median":-2.318372,"eighty":-1.531231,"marketCap":33112839},{"date":"2026-02-20","current":-3.395977,"twenty":-3.663107,"median":-2.321244,"eighty":-1.532909,"marketCap":29402373},{"date":"2026-02-27","current":-3.478524,"twenty":-3.655969,"median":-2.323708,"eighty":-1.541596,"marketCap":30117061},{"date":"2026-03-06","current":-3.294916,"twenty":-3.65442,"median":-2.343329,"eighty":-1.545474,"marketCap":28527382},{"date":"2026-03-13","current":-3.278715,"twenty":-3.645447,"median":-2.34536,"eighty":-1.545474,"marketCap":28387116},{"date":"2026-03-20","current":-3.042262,"twenty":-3.644559,"median":-2.34941,"eighty":-1.547548,"marketCap":26339904},{"date":"2026-03-27","current":-2.97013,"twenty":-3.632927,"median":-2.354945,"eighty":-1.547626,"marketCap":25715388},{"date":"2026-04-02","current":-2.281476,"twenty":-3.629959,"median":-2.358675,"eighty":-1.552913,"marketCap":25381422},{"date":"2026-04-10","current":-2.319583,"twenty":-3.623028,"median":-2.361217,"eighty":-1.556829,"marketCap":25805363},{"date":"2026-04-17","current":-2.249678,"twenty":-3.618913,"median":-2.349527,"eighty":-1.558428,"marketCap":25027667},{"date":"2026-04-24","current":-2.271603,"twenty":-3.616161,"median":-2.347643,"eighty":-1.562107,"marketCap":25271581},{"date":"2026-05-01","current":-2.608737,"twenty":-3.615634,"median":-2.349527,"eighty":-1.569077,"marketCap":29022196},{"date":"2026-05-08","current":-2.786677,"twenty":-3.615634,"median":-2.361217,"eighty":-1.570604,"marketCap":31001786},{"date":"2026-05-15","current":-2.703744,"twenty":-3.615634,"median":-2.364625,"eighty":-1.571206,"marketCap":30079155},{"date":"2026-05-22","current":-2.456216,"twenty":-3.615634,"median":-2.366966,"eighty":-1.575541,"marketCap":27325405},{"date":"2026-05-29","current":-2.73266,"twenty":-3.607395,"median":-2.367706,"eighty":-1.577309,"marketCap":30400839},{"date":"2026-06-05","current":-2.478777,"twenty":-3.601464,"median":-2.37323,"eighty":-1.581017,"marketCap":27576389},{"date":"2026-06-12","current":-2.348181,"twenty":-3.597278,"median":-2.378341,"eighty":-1.583224,"marketCap":26123511},{"date":"2026-06-18","current":-2.240145,"twenty":-3.591493,"median":-2.370394,"eighty":-1.583576,"marketCap":24921618},{"date":"2026-06-26","current":-2.411731,"twenty":-3.586709,"median":-2.383451,"eighty":-1.584886,"marketCap":26830508},{"date":"2026-07-02","current":-2.297341,"twenty":-3.586709,"median":-2.37323,"eighty":-1.586142,"marketCap":25557914},{"date":"2026-07-10","current":-2.28749,"twenty":-3.586709,"median":-2.367706,"eighty":-1.588053,"marketCap":25448330},{"date":"2026-07-17","current":-2.231566,"twenty":-3.586709,"median":-2.36665,"eighty":-1.595705,"marketCap":24826173},{"date":"2026-07-24","current":-2.08127,"twenty":-3.585446,"median":-2.364192,"eighty":-1.59597,"marketCap":23154127},{"date":"2026-07-31","current":-1.512495,"twenty":-3.580392,"median":-2.361217,"eighty":-1.595698,"marketCap":16826510},{"date":"2026-08-07","current":-1.598288,"twenty":-3.579855,"median":-2.349527,"eighty":-1.586142,"marketCap":17780955},{"date":"2026-08-14","current":-1.472608,"twenty":-3.578812,"median":-2.348737,"eighty":-1.583261,"marketCap":16382765},{"date":"2026-08-21","current":-1.164527,"twenty":-3.572247,"median":-2.34536,"eighty":-1.571357,"marketCap":12955362},{"date":"2026-08-28","current":-1.45865,"twenty":-3.571281,"median":-2.343329,"eighty":-1.558666,"marketCap":16227478}],"updateTime":1788221571077},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NRSN\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2623457582","title":"Israel's NeuroSense Therapeutics 2025 net loss widens as expenses rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2623457582","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623457582?lang=en_us&edition=fundamental","pubTime":"2026-03-31 21:31","pubTimestamp":1774963896,"startTime":"0","endTime":"0","summary":"Israel's NeuroSense Therapeutics 2025 net loss widens as expenses riseOverviewIsrael biotechnology firm's 2025 net loss widened, with increased R&D and admin expensesCompany advanced PrimeC into late-","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nL1N40J0N7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623582379","title":"BRIEF-NeuroSense Therapeutics FY EPS USD -0.44","url":"https://stock-news.laohu8.com/highlight/detail?id=2623582379","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623582379?lang=en_us&edition=fundamental","pubTime":"2026-03-31 21:20","pubTimestamp":1774963245,"startTime":"0","endTime":"0","summary":"BRIEF-NeuroSense Therapeutics FY EPS USD -0.44\n\n\nMar 31 (Reuters) - NeuroSense Therapeutics FY operating income USD -11.085 million.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nPLXDE3163:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623858281","title":"Neurosense Therapeutics FY Operating Income USD -11.085 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2623858281","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623858281?lang=en_us&edition=fundamental","pubTime":"2026-03-31 21:20","pubTimestamp":1774963201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nPLXDE3163:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623582813","title":"Neurosense Therapeutics FY EPS USD -0.44","url":"https://stock-news.laohu8.com/highlight/detail?id=2623582813","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623582813?lang=en_us&edition=fundamental","pubTime":"2026-03-31 21:20","pubTimestamp":1774963201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nPLXDE3163:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623258236","title":"Press Release: NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2623258236","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623258236?lang=en_us&edition=fundamental","pubTime":"2026-03-31 21:20","pubTimestamp":1774963200,"startTime":"0","endTime":"0","summary":"-- 2025 marked transition of PrimeC into a late-stage clinical asset with. -- Statistically significant survival benefit demonstrated, including 65%. reduction in risk of death and >14-month median survival advantage. -- Results published in JAMA Neurology, providing high-level peer-reviewed. CAMBRIDGE, Mass., March 31, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd.  , a late-stage clinical biotechnology company developing treatments for severe neurodegenerative diseases, today reported its financial results for the year ended December 31, 2025 and provided a business update.\"2025 was a transformational year for NeuroSense, as we advanced PrimeC from a successful Phase 2b program into a late-stage clinical asset with a clear regulatory path forward,\" said Alon Ben-Noon, Chief Executive Officer of NeuroSense. \"As we entered 2026, we further strengthened our clinical and scientific foundation with statistically significant survival data and publication of our results in JAMA Neurology","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LENZ","BK4007","NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623324643","title":"NeuroSense files Form 3 for CTO Niva Russek-Blum initial beneficial ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2623324643","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623324643?lang=en_us&edition=fundamental","pubTime":"2026-03-31 05:38","pubTimestamp":1774906707,"startTime":"0","endTime":"0","summary":"NeuroSense Therapeutics CTO Niva Russek-Blum reported direct holdings of 258,000 ordinary shares as of March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 30, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDLc9dg9M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623834882","title":"NeuroSense CEO Alon Ben-Noon files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2623834882","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623834882?lang=en_us&edition=fundamental","pubTime":"2026-03-30 20:52","pubTimestamp":1774875168,"startTime":"0","endTime":"0","summary":"NeuroSense Therapeutics CEO Alon Ben-Noon filed an initial Form 3 disclosing direct ownership of about 4.2 million ordinary shares as of March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 30, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL1P6QTQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621067279","title":"NeuroSense to report clinical and biomarker results from Alzheimer’s study in coming weeks","url":"https://stock-news.laohu8.com/highlight/detail?id=2621067279","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621067279?lang=en_us&edition=fundamental","pubTime":"2026-03-24 21:03","pubTimestamp":1774357439,"startTime":"0","endTime":"0","summary":"NeuroSense rescheduled its pre-New Drug Submission meeting with Health Canada to May 2026 to include additional clinical, biomarker, and survival analyses for PrimeC.Clinical and biomarker results from NeuroSense’s Alzheimer’s study have not yet been presented and are expected in the coming weeks.The company cited prior data showing a 65% reduction in risk of death associated with PrimeC.NeuroSense said the FDA has cleared initiation of the Phase 3 PARAGON trial in ALS.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL8zlKf9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620208261","title":"NeuroSense Therapeutics Director Cary J. Claiborne Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620208261","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620208261?lang=en_us&edition=fundamental","pubTime":"2026-03-19 03:36","pubTimestamp":1773862603,"startTime":"0","endTime":"0","summary":"NeuroSense Therapeutics director Cary Claiborne filed an initial statement of beneficial ownership. Claiborne reported directly owning 48,000 ordinary shares. He also reported directly owning 60,000 ordinary shares and 99,898 ordinary shares. Claiborne reported options to purchase 72,000 ordinary shares at an exercise price of USD 1.43.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL4mh6sd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620261222","title":"NeuroSense Therapeutics Ltd. Director Roy Golan Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620261222","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620261222?lang=en_us&edition=fundamental","pubTime":"2026-03-19 03:36","pubTimestamp":1773862587,"startTime":"0","endTime":"0","summary":"NeuroSense Therapeutics reported an initial statement of beneficial ownership for director Roy Golan. Golan reported direct beneficial ownership of 24,000 ordinary shares. Golan also reported direct beneficial ownership of 60,000 ordinary shares. Golan also reported direct beneficial ownership of 76,844 ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL6Gn9Mg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620261270","title":"NeuroSense Therapeutics Ltd. Director Mark Leuchtenberger Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620261270","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620261270?lang=en_us&edition=fundamental","pubTime":"2026-03-19 03:36","pubTimestamp":1773862576,"startTime":"0","endTime":"0","summary":"NeuroSense Therapeutics reported an initial statement of beneficial ownership by director Mark Leuchtenberger. Mark Leuchtenberger reported direct beneficial ownership of 128,000 ordinary shares. He also reported direct beneficial ownership of 75,000 ordinary shares. He also reported direct beneficial ownership of 122,951 ordinary shares. Mark Leuchtenberger reported fully vested options to purchase 192,000 ordinary shares at a conversion or exercise price of USD 4.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL9zB1kW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620726127","title":"NeuroSense Therapeutics Ltd. files Form 3 initial beneficial ownership statement for General Manager Hagit Binder","url":"https://stock-news.laohu8.com/highlight/detail?id=2620726127","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620726127?lang=en_us&edition=fundamental","pubTime":"2026-03-19 03:36","pubTimestamp":1773862566,"startTime":"0","endTime":"0","summary":"NeuroSense Therapeutics reported an initial statement of beneficial ownership by Hagit Binder, its General Manager. Binder reported direct ownership of 12,836 ordinary shares. She also reported direct ownership of 32,000 ordinary shares. Binder reported direct ownership of 266,970 ordinary shares. She reported options to purchase 36,000 ordinary shares with an exercise price of USD 2.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL2pP3lx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620253314","title":"NeuroSense to Present PrimeC Phase 2b PARADIGM Data at AD/PD 2026 Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2620253314","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620253314?lang=en_us&edition=fundamental","pubTime":"2026-03-18 20:04","pubTimestamp":1773835472,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via PR Newswire  on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL1fLsDM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620470649","title":"Health Rounds: Blood test improves detection of endometriosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2620470649","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620470649?lang=en_us&edition=fundamental","pubTime":"2026-03-18 03:31","pubTimestamp":1773775865,"startTime":"0","endTime":"0","summary":"Health Rounds: Blood test improves detection of endometriosis Health Rounds is published on Tuesdays and Thursdays. Think your friend or colleague should know about us?Forward this newsletter to them. They can also subscribe hereBy Nancy LapidMarch 17  - Hello Health Rounds readers!","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nL1N4050X2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1839511570.USD","BK4588","NRSN","LU2087621335.USD","BK4583","BK4007","BK4585","BK4139","VTRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620405478","title":"Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN), Assertio Therapeutics (ASRT) and LENSAR (LNSR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2620405478","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620405478?lang=en_us&edition=fundamental","pubTime":"2026-03-17 21:40","pubTimestamp":1773754806,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Neurosense Therapeutics Ltd. (NRSN – Research Repo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurosense-therapeutics-ltd-nrsn-assertio-therapeutics-asrt-and-lensar-lnsr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurosense-therapeutics-ltd-nrsn-assertio-therapeutics-asrt-and-lensar-lnsr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNSR","BK4588","BK4137","LU0128526141.USD","HCSG","XLV","NRSN","LABU","LU0029874061.USD","BK4581","BK4007","ASRT","XBI","BK4585","BK4082","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619462144","title":"NeuroSense Phase 2b PARADIGM trial links PrimeC to 36% slower ALS progression and 64% lower complication risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2619462144","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619462144?lang=en_us&edition=fundamental","pubTime":"2026-03-16 23:34","pubTimestamp":1773675245,"startTime":"0","endTime":"0","summary":"NeuroSense reported that results from its PARADIGM Phase 2b randomized, double-blind, placebo-controlled trial of PrimeC in amyotrophic lateral sclerosis were published in JAMA Neurology, following a 6-month blinded period and a 12-month open-label extension. Continuous PrimeC treatment was associated with a 7.92-point ALSFRS-R advantage at 18 months versus placebo, and a 64% relative reduction in risk of ALS-related complications with early initiation. The publication also reported modulation of ALS-related microRNAs and iron-regulatory biomarkers, including downregulation of miR-199a-3p and stabilization of ferritin. NeuroSense said the findings supported advancement of PrimeC to a confirmatory Phase 3 trial in ALS, and that the Phase 3 trial has received FDA clearance to proceed.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL94Rthf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619111462","title":"Jama Neurology Publishes Results From Paradigm Phase 2B Trial of Primec in ALS Demonstrating Meaningful Clinical Outcomes and Biological Activity","url":"https://stock-news.laohu8.com/highlight/detail?id=2619111462","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619111462?lang=en_us&edition=fundamental","pubTime":"2026-03-16 23:33","pubTimestamp":1773675222,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nTUA4TXKPT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NRSNW","NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618944271","title":"NeuroSense Therapeutics shareholders approve articles amendment to increase registered share capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2618944271","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618944271?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:02","pubTimestamp":1773230531,"startTime":"0","endTime":"0","summary":"NeuroSense shareholders approved a resolution at a March 10, 2026 special meeting to amend the company’s articles of association to increase its registered share capital.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 11, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDL9JL6P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NRSN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618932751","title":"Roth Capital Partners Initiates Neurosense Therapeutics at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2618932751","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618932751?lang=en_us&edition=fundamental","pubTime":"2026-03-10 19:35","pubTimestamp":1773142532,"startTime":"0","endTime":"0","summary":"Roth Capital Partners Initiates Neurosense Therapeutics at Buy","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","NRSN","LENZ","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618938379","title":"NeuroSense initiated with a Buy at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2618938379","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618938379?lang=en_us&edition=fundamental","pubTime":"2026-03-10 16:30","pubTimestamp":1773131439,"startTime":"0","endTime":"0","summary":"Roth Capital analyst Boobalan Pachaiyappan initiated coverage of NeuroSense (NRSN) with a Buy rating and $3 price target The firm is positive on Pr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurosense-initiated-with-a-buy-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurosense-initiated-with-a-buy-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NRSN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":61,"code":"91000000","status":"200"}]}}